Vascular smooth muscle cell signaling mechanisms for contraction to angiotensin II and endothelin-1

Journal of the American Society of Hypertension

Volumn 3, Issue 2, 2009, Pages 84-95

  Wynne, Brandi M ^a   Chiao, Chin Wei ^a   Webb, R Clinton ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Calcium channel; phosphoinositides; Rho kinase; vasoactive peptides

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN II; DIACYLGLYCEROL; ENDOTHELIN 1; INOSITOL TRISPHOSPHATE; MYOSIN LIGHT CHAIN; PHOSPHATASE; PHOSPHOLIPASE C; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL; VOLTAGE GATED CALCIUM CHANNEL;

CALCIUM TRANSPORT; ENZYME ACTIVATION; HUMAN; HYPERTENSION; MOLECULAR MECHANICS; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 62549094375     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2008.09.002     Document Type: Review

References (94)

1. Jackson W.F. Ion channels and vascular tone. Hypertension 35 (2000) 173-178
2. Hilgers R.H., and Webb R.C. Molecular aspects of arterial smooth muscle contraction: focus on Rho. Exp Biol Med (Maywood) 230 (2005) 829-835
3. Woodrum D.A., and Brophy C.M. The paradox of smooth muscle physiology. Mol Cell Endocrinol 177 (2001) 135-143
4. Wamhoff B.R., Bowles D.K., and Owens G.K. Excitation-transcription coupling in arterial smooth muscle. Circ Res 98 (2006) 868-878
5. Higuchi S., Ohtsu H., Suzuki H., Shirai H., Frank G.D., and Eguchi S. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 112 (2007) 417-428
6. Ohtsu H., Suzuki H., Nakashima H., Dhobale S., Frank G.D., Motley E.D., et al. Angiotensin II signal transduction through small GTP-binding proteins: mechanism and significance in vascular smooth muscle cells. Hypertension 48 (2006) 534-540
7. Touyz R.M., and Berry C. Recent advances in angiotensin II signaling. Braz J Med Biol Res 35 (2002) 1001-1015
8. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 83 (1998) 1182-1191
9. Harris D.M., Cohn H.I., Pesant S., Zhou R.H., and Eckhart A.D. Vascular smooth muscle G(q) signaling is involved in high blood pressure in both induced renal and genetic vascular smooth muscle-derived models of hypertension. Am J Physiol Heart Circ Physiol 293 (2007) H3072-H3079
10. Wirth A., Benyo Z., Lukasova M., Leutgeb B., Wettschureck N., Gorbey S., et al. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med 14 (2008) 64-68
11. Ohtsu H., Higuchi S., Shirai H., Eguchi K., Suzuki H., Hinoki A., et al. Central role of Gq in the hypertrophic signal transduction of angiotensin II in vascular smooth muscle cells. Endocrinology 149 (2008) 3569-3575
12. Woodsome T.P., Polzin A., Kitazawa K., Eto M., and Kitazawa T. Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells. J Cell Sci 119 (2006) 1769-1780
13. (2+) release and ATP-dependent facilitation of arterial myocyte contraction. Proc Natl Acad Sci U S A 103 (2006) 4316-4321
14. 2+ channel-induced calcium release in vascular smooth muscle. Cell Calcium 42 (2007) 513-520
15. Bouallegue A., Daou G.B., and Srivastava A.K. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway. Am J Physiol Heart Circ Physiol 293 (2007) H2072-H2079
16. Lesh R.E., Nixon G.F., Fleischer S., Airey J.A., Somlyo A.P., and Somlyo A.V. Localization of ryanodine receptors in smooth muscle. Circ Res 82 (1998) 175-185
17. Hirano K. Current topics in the regulatory mechanism underlying the Ca2+ sensitization of the contractile apparatus in vascular smooth muscle. J Pharmacol Sci 104 (2007) 109-115
18. Hilgers R.H., Todd Jr. J., and Webb R.C. Increased PDZ-RhoGEF/RhoA/Rho kinase signaling in small mesenteric arteries of angiotensin II-induced hypertensive rats. J Hypertens 25 (2007) 1687-1697
19. Kamm K.E., and Murphy R.A. Velocity and myosin phosphorylation transients in arterial smooth muscle: effects of agonist diffusion. Experientia 41 (1985) 1010-1017
20. Kamm K.E., and Stull J.T. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Ann Rev Pharmacol Toxicol 25 (1985) 593-620
21. Gallagher P.J., Herring B.P., and Stull J.T. Myosin light chain kinases. J Muscle Res Cell Motil 18 (1997) 1-16
22. Chitaley K., Weber D., and Webb R.C. RhoA/Rho-kinase, vascular changes, and hypertension. Curr Hypertens Rep 3 (2001) 139-144
23. Schmidt A., and Hall A. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev 16 (2002) 1587-1609
24. Uehata M., Ishizaki T., Satoh H., Ono T., Kawahara T., Morishita T., et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389 (1997) 990-994
25. Miwa S., Iwamuro Y., Zhang X.F., Inoki T., Okamoto Y., Okazawa M., et al. Ca2+ entry channels in rat thoracic aortic smooth muscle cells activated by endothelin-1. Jpn J Pharmacol 80 (1999) 281-288
26. Yanagisawa M., Inoue A., Ishikawa T., Kasuya Y., Kimura S., Kumagaye S., et al. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci U S A 85 (1988) 6964-6967
27. 2+ channels. J Hypertens Suppl 6 (1988) S188-S191
28. 2+ entry channels involved in endothelin-1-induced contractions of vascular smooth muscle cells. J Smooth Muscle Res 41 (2005) 61-75
29. Mohacsi A., Magyar J., Tamas B., and Nanasi P.P. Effects of endothelins on cardiac and vascular cells: new therapeutic target for the future?. Curr Vasc Pharmacol 2 (2004) 53-63
30. Neylon C.B. Vascular biology of endothelin signal transduction. Clin Exp Pharmacol Physiol 26 (1999) 149-153
31. + channels in ETB-induced relaxation. Br J Pharmacol 146 (2005) 903-912
32. Robin P., Boulven I., Desmyter C., Harbon S., and Leiber D. ET-1 stimulates ERK signaling pathway through sequential activation of PKC and Src in rat myometrial cells. Am J Physiol Cell Physiol 283 (2002) C251-C260
33. Hilal-Dandan R., Ramirez M.T., Villegas S., Gonzalez A., Endo-Mochizuki Y., Brown J.H., et al. Endothelin ETA receptor regulates signaling and ANF gene expression via multiple G-protein-linked pathways. Am J Physiol 272 (1997) H130-H137
34. Aramori I., and Nakanishi S. Coupling of two endothelin receptor subtypes to differing signal transduction in transfected Chinese hamster ovary cells. J Biol Chem 267 (1992) 12468-12474
35. 2+ entry mechanisms of vascular contraction are enhanced during high-salt diet. Hypertension 41 (2003) 787-793
36. Dammanahalli J.K., and Sun Z. Endothelin-1 Inhibits NADPH oxidase activity in human abdominal aortic endothelial cells: a novel function of ETB1 receptors. Endocrinology 149 (2008) 4979-4987
37. Douglas J.T., and Curiel D.T. Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors. Neuromuscul Disord 7 (1997) 284-298
38. Rubanyi G.M., and Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46 (1994) 325-415
39. 2+-permeable nonselective cation channel in endothelin-1-induced contraction of rabbit aorta. J Cardiovasc Pharmacol 30 (1997) 504-509
40. Dostal D.E., Murahashi T., and Peach M.J. Regulation of cytosolic calcium by angiotensins in vascular smooth muscle. Hypertension 15 (1990) 815-822
41. 2+ channels involved in endothelin-1-induced contraction of rabbit basilar artery. J Cardiovasc Pharmacol 40 (2002) 438-447
42. Yogi A., Callera G.E., Montezano A.C., Aranha A.B., Tostes R.C., Schiffrin E.L., et al. Endothelin-1, but not Ang II, activates MAP kinases through c-Src independent Ras-Raf dependent pathways in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 27 (2007) 1960-1967
43. Bolton T.B. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 59 (1979) 606-718
44. Hughes A.D. Calcium channels in vascular smooth muscle cells. J Vasc Res 32 (1995) 353-370
45. 2+ channel in vascular smooth muscle. Proc Natl Acad Sci U S A 86 (1989) 3915-3918
46. 2+ channels and phosphoinositide 3-kinase in endothelin-1-induced PYK2 tyrosine phosphorylation. Mol Pharmacol 63 (2003) 808-813
47. (2+) channels in arterial myocytes. Hypertension 39 (2002) 474-478
48. Ohya Y., and Sperelakis N. Involvement of a GTP-binding protein in stimulating action of angiotensin II on calcium channels in vascular smooth muscle cells. Circ Res 68 (1991) 763-771
49. Wayman C.P., McFadzean I., Gibson A., and Tucker J.F. Two distinct membrane currents activated by cyclopiazonic acid-induced calcium store depletion in single smooth muscle cells of the mouse anococcygeus. Br J Pharmacol 117 (1996) 566-572
50. 2+ mobilizing second messenger - cyclic ADP-ribose. J Cell Mol Med 10 (2006) 407-422
51. Putney Jr. J.W. A model for receptor-regulated calcium entry. Cell Calcium 7 (1986) 1-12
52. Benham C.D., Hess P., and Tsien R.W. Two types of calcium channels in single smooth muscle cells from rabbit ear artery studied with whole-cell and single-channel recordings. Circ Res 61 (1987) I10-I16
53. + channels. Nature 330 (1987) 653-655
54. Kuno M., and Gardner P. Ion channels activated by inositol 1,4,5-trisphosphate in plasma membrane of human T-lymphocytes. Nature 326 (1987) 301-304
55. Saleh S.N., Albert A.P., Peppiatt C.M., and Large W.A. Angiotensin II activates two cation conductances with distinct TRPC1 and TRPC6 channel properties in rabbit mesenteric artery myocytes. J Physiol 577 (2006) 479-495
56. 3 receptor-mediated activation of TRPC1. Eur J Pharmacol 583 (2008) 135-147
57. 2+-permeable cation channel with TRPC3 and TRPC7 properties in rabbit coronary artery myocytes. J Physiol 580 (2007) 755-764
58. 2+ entry: roles of Orai, STIM and TRP. Biochim Biophys Acta 1763 (2006) 1147-1160
59. Putney Jr. J.W., and McKay R.R. Capacitative calcium entry channels. Bioessays 21 (1999) 38-46
60. Nilius B., and Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev 81 (2001) 1415-1459
61. Parekh A.B., and Putney Jr. J.W. Store-operated calcium channels. Physiol Rev 85 (2005) 757-810
62. Leung F.P., Yung L.M., Yao X., Laher I., and Huang Y. Store-operated calcium entry in vascular smooth muscle. Br J Pharmacol 153 (2008) 846-857
63. Putney Jr. J.W. Capacitative calcium entry revisited. Cell Calcium 11 (1990) 611-624
64. Putney Jr. J.W. Receptor-regulated calcium entry. Pharmacol Ther 48 (1990) 427-434
65. Putney Jr. J.W. The integration of receptor-regulated intracellular calcium release and calcium entry across the plasma membrane. Curr Top Cell Regul 31 (1990) 111-127
66. Kasuya Y., Ishikawa T., Yanagisawa M., Kimura S., Goto K., and Masaki T. Mechanism of contraction to endothelin in isolated porcine coronary artery. Am J Physiol 257 (1989) H1828-H1835
67. Takemura H., Thastrup O., and Putney Jr. J.W. Calcium efflux across the plasma membrane of rat parotid acinar cells is unaffected by receptor activation or by the microsomal calcium ATPase inhibitor, thapsigargin. Cell Calcium 11 (1990) 11-17
68. Putney Jr. J.W., Broad L.M., Braun F.J., Lievremont J.P., and Bird G.S. Mechanisms of capacitative calcium entry. J Cell Sci 114 (2001) 2223-2229
69. Bouallegue A., and Yamaguchi N. Nitric oxide inhibits the bradykinin B2 receptor-mediated adrenomedullary catecholamine release but has no effect on adrenal blood flow response in vivo. J Pharmacol Sci 98 (2005) 151-160
70. Venkatachalam K., van Rossum D.B., Patterson R.L., Ma H.T., and Gill D.L. The cellular and molecular basis of store-operated calcium entry. Nat Cell Biol 4 (2002) E263-E272
71. 2+ channel function. J Cell Biol 169 (2005) 435-445
72. 2+ store to the plasma membrane. Nature 437 (2005) 902-905
73. 2+ influx. Curr Biol 15 (2005) 1235-1241
74. Takahashi Y., Watanabe H., Murakami M., Ohba T., Radovanovic M., Ono K., et al. Involvement of transient receptor potential canonical 1 (TRPC1) in angiotensin II-induced vascular smooth muscle cell hypertrophy. Atherosclerosis 195 (2007) 287-296
75. Chen C., and Wagoner P.K. Endothelin induces a nonselective cation current in vascular smooth muscle cells. Circ Res 69 (1991) 447-454
76. Enoki T., Miwa S., Sakamoto A., Minowa T., Komuro T., Kobayashi S., et al. Long-lasting activation of cation current by low concentration of endothelin-1 in mouse fibroblasts and smooth muscle cells of rabbit aorta. Br J Pharmacol 115 (1995) 479-485
77. Kasuya Y., Takuwa Y., Yanagisawa M., Kimura S., Goto K., and Masaki T. Endothelin-1 induces vasoconstriction through two functionally distinct pathways in porcine coronary artery: contribution of phosphoinositide turnover. Biochem Biophys Res Commun 161 (1989) 1049-1055
78. 2+ channels and vasoconstriction. Biochem Pharmacol 68 (2004) 215-221
79. Schoner W. Salt abuse: the path to hypertension. Nat Med 14 (2008) 16-17
80. Giachini F.R.C., Carneiro F.S., Lima V.V., Carneiro Z.N., Carvalho M.H.C., Fortes Z.B., et al. Pyk2 mediates increased adrenergic contractile responses in arteries from DOCA-salt mice. J Am Soc Hypertens 2 (2008) 431-438
81. Yin G., Yan C., and Berk B.C. Angiotensin II signaling pathways mediated by tyrosine kinases. Int J Biochem Cell Biol 35 (2003) 780-783
82. Bouallegue A., Daou G.B., and Srivastava A.K. Endothelin-1-induced signaling pathways in vascular smooth muscle cells. Curr Vasc Pharmacol 5 (2007) 45-52
83. Schaller M.D. Calcium-dependent Pyk2 activation: a role for calmodulin?. Biochem J 410 (2008) e3-e4
84. Berk B.C. Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases. J Am Soc Nephrol 11 (1999) S62-S68
85. Soboloff J., Spassova M.A., Tang X.D., Hewavitharana T., Xu W., and Gill D.L. Orai1 and STIM reconstitute store-operated calcium channel function. J Biol Chem 281 (2006) 20661-20665
86. (2+) channels. Proc Natl Acad Sci U S A 103 (2006) 4040-4045
87. Manji S.S., Parker N.J., Williams R.T., van Stekelenburg L., Pearson R.B., Dziadek M., et al. STIM1: a novel phosphoprotein located at the cell surface. Biochim Biophys Acta 1481 (2000) 147-155
88. Soboloff J., Spassova M.A., Dziadek M.A., and Gill D.L. Calcium signals mediated by STIM and Orai proteins-a new paradigm in inter-organelle communication. Biochim Biophys Acta 1763 (2006) 1161-1168
89. 2+ Entry. Curr Biol 16 (2006) 1465-1470
90. Coffman T.M., and Crowley S.D. Kidney in hypertension: Guyton redux. Hypertension 51 (2008) 811-816
91. Guyton A.C. Blood pressure control-special role of the kidneys and body fluids. Science 252 (1991) 1813-1816
92. Coffman T.M., Himmelstein S., Best C., and Klotman P.E. Post-transplant hypertension in the rat: effects of captopril and native nephrectomy. Kidney Int 36 (1989) 35-40
93. Crowley S.D., Gurley S.B., Herrera M.J., Ruiz P., Griffiths R., Kumar A.P., et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 103 (2006) 17985-17990
94. Michael S.K., Surks H.K., Wang Y., Zhu Y., Blanton R., Jamnongjit M., et al. High blood pressure arising from a defect in vascular function. Proc Natl Acad Sci U S A 105 (2008) 6702-6707